España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
EA Series Trust MRBL Enhanced Equity ETF
EDGE
BATS
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$40.00
-0.18
-0.44%
At close: -
Get Report
Comment
Overview
News
Holdings
Dividends
Short Interest
Latest news for EA Series Trust MRBL Enhanced Equity ETF (BATS:EDGE)
EA Series Trust MRBL Enhanced Equity ETF (BATS: EDGE)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, March 15, 2019
Hearing Merger Of Edge Therapeutics And PDS B...
Benzinga Newsdesk
Thursday, February 21, 2019
Edge Therapeutics FY18 EPS $(1.31) vs $(1.67)...
Benzinga Newsdesk
Edge Therapeutics Says Biotechnology Merger I...
Charles Gross
Friday, December 21, 2018
The Daily Biotech Pulse: Proteostasis Delays Data, Akron Gets New CEO, Pfizer Halts Vaccine Trial
Shanthi Rexaline
Thursday, December 20, 2018
The Daily Biotech Pulse: Tilray Inks Cannabis Drink Pact, Double Delight For Merck, FDA Snub For Spectrum
Shanthi Rexaline
Wednesday, December 19, 2018
The Daily Biotech Pulse: Pfizer-Glaxo Set Up Consumer Health Care Venture, New Patent For Adamas
Shanthi Rexaline
Tuesday, December 18, 2018
The Daily Biotech Pulse: Puma Aces Late-Stage Trial, Chinese Cheer For FiborGen, J&J $5B Buyback Plan
Shanthi Rexaline
Monday, December 17, 2018
Stocks Which Set New 52-Week Low Last Trading...
Benzinga Newsdesk
Friday, December 14, 2018
Stocks Which Set New 52-Week Low Yesterday, T...
Benzinga Newsdesk
Tuesday, December 11, 2018
The Daily Biotech Pulse: Management Change At Merck, Jazz Buyback, Arrowhead Earnings
Shanthi Rexaline
Friday, December 07, 2018
The Daily Biotech Pulse: FDA Nod For Roche, Bristol-Myers Hikes Dividend, 2 Biotechs To Debut
Shanthi Rexaline
Friday, November 30, 2018
Edge Therapeutics Shares Spike ~14% Higher On...
Benzinga Newsdesk
Wednesday, November 28, 2018
Stocks Which Set New 52-Week Low Yesterday Tu...
Benzinga Newsdesk
The Daily Biotech Pulse: IntelliPharmaCeutics Generic Antidepressant Gets FDA Nod, GW Pharma Earnings
Shanthi Rexaline
Tuesday, November 27, 2018
Stocks Which Set New 52-Week Low Yesterday, M...
Benzinga Newsdesk
Monday, November 26, 2018
Edge Therapeutics, Privately Held PDS Biotech Announce Reverse Merger
Shanthi Rexaline
Benzinga Pro's Top 10 Most-Searched Tickers F...
Benzinga Newsdesk
Edge Therapeutics shares are trading higher a...
Benzinga Newsdesk
Edge Therapeutics to Merge with PDS Biotechno...
Benzinga Newsdesk
Wednesday, November 14, 2018
The Daily Biotech Pulse: Mallinckrodt Faces FDA Panel, Reshape's Earnings, Vapotherm To Debut
Shanthi Rexaline
Thursday, November 08, 2018
Stocks Which Set New 52-Week Low Yesterday, W...
Benzinga Newsdesk
Thursday, November 01, 2018
Edge Therapeutics Q3 EPS $(0.14) Up From $(0....
Benzinga Newsdesk
Wednesday, September 19, 2018
The Daily Biotech Pulse: Johnson & Johnson's Generic Unit Files NDA For Urinary Tract Cancer Drug, G1 Therapeutics Prices Offering
Shanthi Rexaline
Tuesday, September 18, 2018
Stocks Which Set New 52-Week Low Yesterday, S...
Benzinga Newsdesk
The Daily Biotech Pulse: Morphosys Expands Collaboration, Osiris Launches Product, Argenx To Offer Shares
Shanthi Rexaline
Friday, September 14, 2018
Stocks Which Set New 52-Week Low Yesterday, S...
Benzinga Newsdesk
The Daily Biotech Pulse: FDA Nod For STAAR, Supernus Opens Wallet, Principia Biopharma To Debut
Shanthi Rexaline
Thursday, August 16, 2018
Stocks Which Set New 52-Week Low Yesterday, A...
Benzinga Newsdesk
Wednesday, August 01, 2018
Edge Therapeutics Q2 EPS $(0.41) Beats $(0.53...
Benzinga Newsdesk
Thursday, July 05, 2018
A Look At Biotech In 2018 And The Biggest Catalysts Coming Up In The Second Half Of The Year
Benzinga
Thursday, June 28, 2018
Benzinga's Daily Biotech Pulse: Eli Lilly, Edge Therapeutics, BioXcel Report Positive Trial Results, 4 Stocks Debut
Benzinga
Wednesday, June 27, 2018
Edge Therapeutics Reports Results Of Phase 3 ...
Benzinga
Thursday, May 24, 2018
Benzinga's Daily Biotech Pulse: Eiger And Melinta Fall On Offerings, Apellis And Marinus Rise On Bullish Ratings
Benzinga
Tuesday, May 22, 2018
Benzinga's Daily Biotech Pulse: Melinta, Ardelyx Pull Back On Offerings, Insys Awaits FDA Verdict
Benzinga
Tuesday, May 01, 2018
Edge Therapeutics Q1 EPS $(0.67) Misses $(0.5...
Benzinga
Monday, April 30, 2018
Benzinga Pro's Most-Searched Tickers For Morning Of Mon., Apr. 30, 2018
Benzinga
Benzinga Pro's 6 Stocks To Watch Today
Benzinga
Edge Therapeutics to Review Strategic Alterna...
Benzinga
Monday, April 02, 2018
41 Biggest Movers From Yesterday
Benzinga
Friday, March 30, 2018
The Week Ahead In Biotech: PDUFA Dates, Clinical Trials And Conferences
Benzinga
Thursday, March 29, 2018
Edge Therapeutics Shares Down 10.7% to $1.17 ...
Benzinga
36 Stocks Moving In Thursday's Mid-Day Session
Benzinga
Benzinga Pro's Top 10 Most-Searched Tickers For Thurs., Mar. 29, 2018
Benzinga
Credit Suisse Slashes Edge Therapeutics Price Target By 94%, Downgrades Stock After Failed Trial
Benzinga
Benzinga's Top Analyst Calls From March 29, 2018
Benzinga
Benzinga's Top Upgrades, Downgrades For March 29, 2018
Benzinga
Credit Suisse Downgrades Edge Therapeutics to Underperform
Benzinga
40 Biggest Movers From Yesterday
Benzinga
Wednesday, March 28, 2018
Mid-Afternoon Market Update: RH Rises On Upbeat Earnings; InspireMD Shares Slide
Benzinga
32 Stocks Moving In Wednesday's Mid-Day Session
Benzinga
Show More